1. Division of Cardiovascular Therapeutics, Gilead Sciences, Palo Alto, California;
2. Joslin Diabetes Center, Boston, Massachusetts;
3. TIMI Study Group, Brigham and Women's Hospital and Department of Medicine, Boston, Massachusetts;
4. Division of Cardiovascular Therapeutics, Gilead Sciences, Foster City, California.